Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
REX American Resources
REX
$1.43B
| $1.64M | ﹤0.01% |
123,186
+2,112
| +2% | +$28.5K |
|
|
EDF
4627
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$167M
| $1.64M | ﹤0.01% |
219,920
+11,713
| +6% | +$97.6K |
|
4628
Ryan Specialty Holdings
RYAN
$5.76B
| $1.64M | ﹤0.01% |
+48,382
| New | +$1.53M |
|
|
EVOP
4629
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.63M | ﹤0.01% |
68,874
-3,254
| -5% | -$86.4K |
|
|
JPN
4630
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
| $1.63M | ﹤0.01% |
48,047
-2,942
| -6% | -$98.3K |
|
4631
First Busey Corp
BUSE
$2.59B
| $1.63M | ﹤0.01% |
66,027
+12,990
| +24% | +$307K |
|
4632
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$107M
| $1.62M | ﹤0.01% |
59,747
+20
| +0% | +$557 |
|
4633
Voyager Therapeutics
VYGR
$189M
| $1.62M | ﹤0.01% |
616,988
-117,621
| -16% | -$382K |
|
|
CLLS
4634
Cellectis
CLLS
$271M
| $1.62M | ﹤0.01% |
128,352
+13,492
| +12% | +$187K |
|
|
FENG
4635
Phoenix New Media
FENG
$17.8M
| $1.62M | ﹤0.01% |
210,597
+29,235
| +16% | +$239K |
|
4636
Viking Therapeutics
VKTX
$3.88B
| $1.62M | ﹤0.01% |
257,739
-190,852
| -43% | -$1.18M |
|
4637
ATN International
ATNI
$471M
| $1.61M | ﹤0.01% |
34,436
-5,668
| -14% | -$257K |
|
4638
Evolus
EOLS
$489M
| $1.61M | ﹤0.01% |
211,257
+24,449
| +13% | +$253K |
|
|
EXTN
4639
DELISTED
Exterran Corporation
EXTN
| $1.61M | ﹤0.01% |
362,128
-225,490
| -38% | -$956K |
|
4640
Puma Biotechnology
PBYI
$413M
| $1.61M | ﹤0.01% |
229,255
+12,304
| +6% | +$92.1K |
|
|
WBK
4641
DELISTED
Westpac Banking Corporation
WBK
| $1.61M | ﹤0.01% |
86,733
-28,293
| -25% | -$528K |
|
4642
Aehr Test Systems
AEHR
$3.25B
| $1.6M | ﹤0.01% |
117,554
+113,354
| +2,699% | +$814K |
|
4643
Cullinan Oncology
CGEM
$1.16B
| $1.6M | ﹤0.01% |
70,799
+4,450
| +7% | +$119K |
|
4644
Payoneer
PAYO
$2.41B
| $1.6M | ﹤0.01% |
186,998
+66,152
| +55% | +$643K |
|
4645
Ecovyst
ECVT
$1.2B
| $1.6M | ﹤0.01% |
136,854
-94,651
| -41% | -$1.29M |
|
4646
The Beachbody Company
BODI
$72.3M
| $1.6M | ﹤0.01% |
5,763
+5,068
| +729% | +$2.03M |
|
4647
Galicia Financial Group
GGAL
$7.51B
| $1.59M | ﹤0.01% |
158,299
+65,563
| +71% | +$600K |
|
|
DCPH
4648
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.59M | ﹤0.01% |
46,931
+2,799
| +6% | +$89.3K |
|
4649
GCM Grosvenor
GCMG
$814M
| $1.59M | ﹤0.01% |
138,214
-3,252
| -2% | -$35.3K |
|
4650
Expro Ltd
XPRO
$1.91B
| $1.59M | ﹤0.01% |
90,196
+24,189
| +37% | +$410K |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,331 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.